✈️ Shipping Update: Delivery times may be longer due to congestion at the air hub. Thank you for your understanding!

Urolesan (40 capsules)

  • $22.00
Sku: 0ba616a0fa1c
The instruction for medical use


of UROLESAN® medicine
the Trade name
of Urolesan®

the International unlicensed name
Is not present

the Dosage form



of the Structure One Capsule Capsule contains
active agent: Urolesanum of extract dense, in terms of moisture of 10% 1 - 10.70 mg, peppermint oils – 7.46 mg, fir oils – 25.50 mg,
excipients: magnesium alyumometasilikat, castor oil, magnesium carbonate heavy, talc, lactoses monohydrate (tablettoza-80), dinatrium edetat (Trilonum B), potato starch,
Structure of the body of the capsule: blue patent V (E 131), yellow quinolinic (E 104), titan dioxide (E 171), iron oxide yellow (E 172), gelatin,
Structure of a lid of the capsule: blue patent V (E 131), yellow quinolinic (E 104), the titan dioxide (E 171), iron oxide yellow (E 172),
gelatin 1 - Urolesanum extract dense contains the dry rest: carrots wild fruits – 1.84 mg, hop of cones – 6.33 mg, a grass marjoram – 1.46 mg

the Description
Solid gelatin capsules number 0, the body and a lid of green color. Contents of capsules – powder from yellow-gray till gray-brown color with a greenish shade with impregnations and a smell of oils of a peppermint and fir.

Pharmacotherapeutic group
Other drugs for urological diseases.
ATX G04BX code

Pharmacological
Combined Drug of Plant Origin properties. Components of the drug Urolesan® reduce the inflammatory phenomena in urinary tract and kidneys, promote the strengthened blood supply of kidneys and a liver, have diuretic, antibacterial, bile-expelling effect, form protective colloid in urine and normalize a tone of smooth muscles of upper uric ways and a gall bladder.
Уролесан® increases discharge of urea and chlorides, promotes removal of small concrements and sand from a bladder and kidneys.

Indications
- acute and persistent infections of urinary tract and kidneys (cystitis and pyelonephritises)
- an urolithiasis and urate diathesis (prevention of formation of concrements after their removal)
- chronic cholecystitises (including calculous), dyskinesia of bilious ways, cholelithiasis.

The route of administration and doses
take the Drug inside to food.
The recommended doses for adults on 1 capsule 3 times a day. At acute conditions (including in renal and hepatic gripes) duration of a course of therapy is from 5 to 7 days, at chronicities – from 7 days to 1 month. When developing renal and hepatic gripes the single dose can be raised once to 2 capsules, then on the subsequent reception to return to a usual single dose (1 capsule).

Side effects
- the dispepsichesky phenomena (nausea, vomiting)
– allergic reactions (feeling of an itching, face reddening, skin rash, a Quincke's disease, feeling of irritation in a throat, breath difficulty, edema of face, language)
– dizziness, the general weakness
– arterial hypertension,

Contraindication hypotension
- hypersensitivity to drug components
– gastritises (except gastritises with secretory insufficiency), a peptic ulcer of a stomach and duodenum
- pregnancy and the period of a lactation
- children's age up to 18 years

Medicinal interactions
Interaction with other medicines is not known.

Special instructions
not to use drug if diameter of concrements exceeds 3 mm.
Features of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms.
Considering a possibility of development of side effects, it is necessary to be careful.

Overdose
Symptoms: nausea, dizziness.
Treatment: plentiful warm drink, rest, activated carbon, Atropini sulfas (0.0005-0.001g).

The form of release and packing
On 10 capsules place in blister strip packaging from a film of the polyvinylchloride and printing aluminum foil varnished.
On the 4th blister strip packagings together with the instruction for medical use in the state and Russian languages put in a pack from cardboard.


To Store storage conditions in original packing at a temperature not above 25 °C.
To store out of children's reach!


2 years
not to apply a period of storage after the expiry date specified on packing!

Prescription status
Without prescription



Ukraine JSC Kiyevmedpreparat Producer, 01032, Kiev, Saksagansky St., 139

the Name and the country of the owner of the registration certificate
of JSC Kiyevmedpreparat, Ukraine

the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products:
Representative office of Arterium corporation in
Republic of Kazakhstan 050060, Almaty, Al-Farabi Avenue 97, 3 entrance, office 54
Ph. / fax: 8 (727) 315-82-09, 8 (727) 315-82-10,
E-mail: office@arterium.kz
Write a review
Related Products
Arapharma Group S.A. (Spain)
Uroseptiki 3g 1's granules for oral solution
$31.40
Dr.R.Pfleger Chemical Factory GmbH (Germany)
Spazmeks 30s 15 mg film-coated tablets
$39.20
Zentiva (Czech Republic)
Penester® (Finasteride) 5 mg, 30 tablets
$30.00
Irbit (Russia)
NITROXOLINE 50 mg, 50 coated tablets
$10.00
Plameca (Spain)
Tsitsibon (30 capsules)
$39.60
Nobel AFF (Kazakhstan)
Sinegra® 12s 50 mg coated tablets
$130.60
Evalar (Russia)
Yohimbe 30s 200 mg capsule
$15.80
Sinton Espana SL (Spain)
Proflosin 30s 0.4 mg modified-release capsules
$44.80